Cargando…
Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy
Targeting the PI3K pathway has achieved limited success in cancer therapy. One reason for the disappointing activity of drugs that interfere with molecules that are important player in this pathway is the induction of multiple feedback loops that have been only partially understood. To understand th...
Autores principales: | Sathe, Anuja, Chalaud, Géraldine, Oppolzer, Immanuel, Wong, Kit Yeng, von Busch, Margarita, Schmid, Sebastian C., Tong, Zhichao, Retz, Margitta, Gschwend, Juergen E., Schulz, Wolfgang A., Nawroth, Roman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777650/ https://www.ncbi.nlm.nih.gov/pubmed/29357370 http://dx.doi.org/10.1371/journal.pone.0190854 |
Ejemplares similares
-
S6K1 and 4E-BP1 Are Independent Regulated and Control Cellular Growth in Bladder Cancer
por: Nawroth, Roman, et al.
Publicado: (2011) -
Functional genomics identifies predictive markers and clinically actionable resistance mechanisms to CDK4/6 inhibition in bladder cancer
por: Tong, Zhichao, et al.
Publicado: (2019) -
mTOR, glycotoxins and the parallel universe
por: Green, Alan S.
Publicado: (2018) -
Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients
por: Heck, Matthias M., et al.
Publicado: (2013) -
Mutant PIK3CA controls DUSP1-dependent ERK 1/2 activity to confer response to AKT target therapy
por: Sathe, A, et al.
Publicado: (2014)